Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.

McPhail S, Barclay ME, Swann R, Johnson SA, Alvi R, Barisic A, Bucher O, Creighton N, Denny CA, Dewar RA, Donnelly DW, Dowden JJ, Downie L, Finn N, Gavin AT, Habbous S, Huws DW, Kumar SE, May L, McClure CA, Morrison DS, Møller B, Musto G, Nilssen Y, Saint-Jacques N, Sarker S, Shack L, Tian X, Thomas RJ, Wang H, Woods RR, You H, Zhang B, Lyratzopoulos G, ICBP Module 9 Radiotherapy Group

Open source

DOI
10.1016/s1470-2045(24)00032-9
Published
2024 Mar
Container
The Lancet. Oncology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s1470-2045-24-00032-9,
  title = {Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.},
  author = {McPhail S and Barclay ME and Swann R and Johnson SA and Alvi R and Barisic A and Bucher O and Creighton N and Denny CA and Dewar RA and Donnelly DW and Dowden JJ and Downie L and Finn N and Gavin AT and Habbous S and Huws DW and Kumar SE and May L and McClure CA and Morrison DS and Møller B and Musto G and Nilssen Y and Saint-Jacques N and Sarker S and Shack L and Tian X and Thomas RJ and Wang H and Woods RR and You H and Zhang B and Lyratzopoulos G and ICBP Module 9 Radiotherapy Group},
  year = {2024},
  journal = {The Lancet. Oncology},
  doi = {10.1016/s1470-2045(24)00032-9},
  url = {https://doi.org/10.1016/s1470-2045(24)00032-9}
}

RIS

TY  - JOUR
TI  - Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
AU  - McPhail S
AU  - Barclay ME
AU  - Swann R
AU  - Johnson SA
AU  - Alvi R
AU  - Barisic A
AU  - Bucher O
AU  - Creighton N
AU  - Denny CA
AU  - Dewar RA
AU  - Donnelly DW
AU  - Dowden JJ
AU  - Downie L
AU  - Finn N
AU  - Gavin AT
AU  - Habbous S
AU  - Huws DW
AU  - Kumar SE
AU  - May L
AU  - McClure CA
AU  - Morrison DS
AU  - Møller B
AU  - Musto G
AU  - Nilssen Y
AU  - Saint-Jacques N
AU  - Sarker S
AU  - Shack L
AU  - Tian X
AU  - Thomas RJ
AU  - Wang H
AU  - Woods RR
AU  - You H
AU  - Zhang B
AU  - Lyratzopoulos G
AU  - ICBP Module 9 Radiotherapy Group
PY  - 2024
JO  - The Lancet. Oncology
DO  - 10.1016/s1470-2045(24)00032-9
UR  - https://doi.org/10.1016/s1470-2045(24)00032-9
ER  - 

APA

S, M., ME, B., R, S., SA, J., R, A., A, B., O, B., N, C., CA, D., RA, D., DW, D., JJ, D., L, D., N, F., AT, G., S, H., DW, H., SE, K., L, M., CA, M., DS, M., B, M., G, M., Y, N., N, S., S, S., L, S., X, T., RJ, T., H, W., RR, W., H, Y., B, Z., G, L., & Group, I. M. 9. R. (2024). Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(24)00032-9

Source records